Related Experiment Video
Updated: Oct 19, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
The RNA binding protein hnRNPK protects against adriamycin-induced podocyte injury
Shili Zhao1,2, Junxia Feng2, Jingchun Li2
1Department of Nephrology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Background:
Podocytes maintain the integrity of the glomerular filtration barrier and serve as the final barrier to protein loss. Podocyte injury may induce severe apoptosis, which can result in serious kidney damage and disease. Therefore, it is necessary to explore how podocyte injury can be prevented and to thereby discover a feasible therapy for kidney disease. However, the mechanism of podocyte injury is still unclear.
Methods:
The mRNA and protein expression levels of synaptopodin and nephrin in MPC5 podocytes with adriamycin (ADR)-induced injury were detected by quantitative real-time PCR and western blot. The expression levels of heterogeneous nucleotide protein K (hnRNPK), caspase-3, Bax, and Bcl-2 protein in cells and tissues were measured using western blot. Proliferation were measured in treated MPC5 podocytes by Cell Counting Kit-8 (CCK-8) assay, EdU assay, and apoptosis was measured by Hoechst 32258 staining. Mitochondrial membrane potential disruption, lactate dehydrogenase (LDH) leakage, and reactive oxygen species (ROS) generation were measured using JC-1 staining, an LDH reagent kit, and a ROS detection kit. Hematoxylin and eosin (HE) staining was used to observe histological changes in mouse tissues.
Results:
Synaptopodin and nephrin were downregulated in ADR-treated podocytes. Overexpression of hnRNPK ameliorated the inhibitive effect of ADR treatment on podocyte proliferation and reduced its promotion of podocyte apoptosis. LDH leakage and ROS generation were increased in ADR-treated podocytes, but were reduced by hnRNPK treatment.
Conclusions:
ADR-induced podocyte injury is ameliorated by hnRNPK both in vivo and in vitro. This observation provides a basis for a feasible therapy to prevent podocyte injury and subsequent kidney disease.
Insights
Heterogeneous nuclear ribonucleoprotein K (hnRNPK) protects against adriamycin-induced podocyte injury. Overexpression of hnRNPK reduced apoptosis and improved cell viability, offering a potential therapy for kidney disease.
Area of Science:
- Nephrology
- Molecular Biology
- Cell Biology
Background:
- Podocytes are crucial for glomerular filtration and preventing protein loss.
- Podocyte injury can lead to apoptosis, kidney damage, and disease.
- Understanding podocyte injury mechanisms is vital for developing effective therapies.
Purpose of the Study:
- To investigate the role of heterogeneous nuclear ribonucleoprotein K (hnRNPK) in adriamycin (ADR)-induced podocyte injury.
- To explore hnRNPK's potential as a therapeutic target for kidney disease.
Main Methods:
- Quantitative real-time PCR and western blot to assess synaptopodin, nephrin, and hnRNPK expression.
- Cell Counting Kit-8, EdU assay, and Hoechst 32258 staining to evaluate proliferation and apoptosis.
- JC-1 staining, LDH assay, and ROS detection kit to measure mitochondrial function and oxidative stress.
- HE staining for histological analysis in mouse models.
Main Results:
- ADR treatment downregulated synaptopodin and nephrin in podocytes.
- hnRNPK overexpression counteracted ADR's negative effects on podocyte proliferation and apoptosis.
- ADR-induced LDH leakage and ROS generation were reduced by hnRNPK treatment.
Conclusions:
- hnRNPK ameliorates ADR-induced podocyte injury both in vitro and in vivo.
- hnRNPK represents a promising therapeutic strategy for preventing podocyte injury and kidney disease.
More Related Videos
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
09:15Monitoring Protein-RNA Interaction Dynamics In Vivo at High Temporal Resolution Using χCRAC
Published on: May 9, 2020
Related Concept Videos
DNA Damage can Stall the Cell Cycle
RNA Stability
RNA Editing
Negative Regulator Molecules
Experimental RNAi
Abnormal Proliferation